Rockwell Medical (NASDAQ:RMTI) is a biopharmaceutical company primarily engaged in the development, manufacture, and distribution of products targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD). Its portfolio includes innovative dialysis concentrates, iron therapies, and medical delivery systems that aim to improve the quality of care and life for patients undergoing dialysis treatment. Rockwell Medical focuses on advancing renal disease treatments through research and innovation, aiming to address the unmet medical needs within the kidney health space. With a commitment to enhancing patient outcomes and expanding its product offerings, Rockwell Medical strives to be at the forefront of kidney health solutions.